Kramer GameChanger Investments web close

Submit Audition/Proposal on this Project
Rate this Project

Project Main Details

Kramer GameChanger Investments web close 
The investing advice world has been dominated by men for... well... forever. A strong female investment advisor is still fairly unusual. Hilary Kramer is a very successful, incredibly talented investment advisor and has made her subscribers piles of money by picking breakout stocks. This audio is intended to close sales at a web landing page to her paid investment advisory newsletter ($200). It's a long audio piece and it will require a credible, mature, strong woman to appeal to a primarily male, over 55, wealthy audience. Not too "girly" -- confident, serious, sincere. 
2011-02-01 08:53:47 GMT
2011-02-05 08:00:00 (GMT -05:00) Eastern Time (US & Canada) 
Yes (click here to learn more about Voice123's SmartCast)
0 direct invitation(s) have been sent by the voice seeker resulting in 0 audition(s) and/or proposal(s) so far.
Voice123 SmartCast is seeking 25 auditions and/or proposals for this project (approx.) Invitations sent by SmartCast have resulted in 0 audition(s) and/or proposal(s) so far.

Project Parameters

The Voice Actor should be located in:
Student or Non-for-profit student project - USD 200
Training, business presentations, sales, and web sites
approximately 22 minutes
English - USA and Canada
See description
Middle Age Female
• Audio files must be delivered via email OR
• Audio files must be delivered via FTP/Dropbox/Google Drive/cloud
• Deliver edited and finished voice tracks
Not defined
This is a non-union project

Script Details

***Require a credible, mature, strong woman to appeal to a primarily male, over 55, wealthy audience. Not too "girly" -- confident, serious, sincere. 
The world’s insatiable demand for energy created lots of new oil and gas millionaires over the last decade. And it will continue to be a dominant trend in the decade ahead--but with new players taking the lead.

If you want to strike it rich from the Great Energy Boom, forget alternative energy. The next big thing over the coming decade will be energy efficiency. And now is the time to stake your claim.

Did you know that we lose more than 10% of the energy we create is lost while being transported from the power source to the end user?

According to the U.S. Department of Energy, increasing energy efficiency could reduce our national energy use by 10% in the next few years and as much as 20% by 2020. No other alternative energy solution can come close to making that kind of massive impact on energy costs and usage so quickly.

Our game-changing stock will be at the forefront of this energy efficiency frenzy as the dominant player in smart metering. Their meters for electricity, water, gas and heat account for 50% of all smart meters installed in US and Canada and 30% worldwide with nearly 8,000 utilities worldwide already using their technology.

Given that only 9% of the meters being used worldwide today are automated, the market growth here is HUGE.

Energy efficiency will be one of the hottest stories of the decade and this juggernaut is the stock to own.

Don’t miss out!

Welcome to the Era of Personalized Medicine
The last decade delivered astounding, life-saving and life-changing medical and scientific discoveries. An artificial liver became a reality. Robots and lasers revolutionized the way surgery is performed. And the human genome was completely mapped.

Thanks to the genome map, the decade ahead will deliver some of the most powerful biotechnology breakthroughs of our lifetime.

The biotech dreams we’ve heard about for years will finally become reality and will revolutionize the way we fight and prevent disease, and treat chronic illness.

We’re ushering in an era of personalized medicine that will see doctors and scientist will develop drugs specifically tailored only to you. The company I’m recommending today is far ahead of its competitors in doing just that.

In an epic breakthrough, after decades of research, this small, little-known biotech company has developed one of the most exciting medical advances of the last 30 years—the first ever cancer vaccine.

This is no “gee-whiz, someday in the future” kind of thing…this drug is already approved and in use.

The treatment takes a patient’s own cells and teaches their immune system to attack cancer cells the way it fights a virus.

The company already has FDA approval to use the drug for a specific type of cancer today. But they are using the same proven technology to develop treatments for other types of cancer, including breast, ovarian and colon cancer.

There is no doubt that when we look back ten years from now, this will be one of the biggest game-changers of the decade. And the company will deliver windfall profits to investors who get on board at the right price.

The last time I recommended this stock, we made 38% in just three days. I expect much bigger returns this time around.

Get immediate online access to all the details—including my exact buy price—on this visionary company when you give my GameChangers service a try thanks. You have nothing to lose thanks to my 100% “you don’t pay if you don’t profit” money-back guarantee. 
Please note that you should only use the script or your recording of it for auditioning purposes. The script is property, unless otherwise specified, of the voice seeker and it is protected by international copyright laws.

Voice-Seeker Details

Sign in to display the company name (if applicable)


Voice123 Team Comments

Voice123 consultations with this voice seeker regarding this project and/or other projects by this voice seeker, via phone, chat, and/or email.

unchecked This project - phone.

unchecked Previous projects - phone.

unchecked This project - email or chat.

checked Previous projects - email or chat.

checked Corporate web site for this voice-seeker confirmed by Voice123

Note: Voice123 strives to establish the legitimacy of all projects posted. However, Voice123 subscribers and users are responsible for confirming information stated by prospective voice seekers, agents and/or clients. Voice123 subscribers and users assume all liability for use of any information found through Voice123, or any of its publications.

This page contains the most important details of this project. If you find the information on this project inaccurate or inappropriate, please let us know by contacting us.

Submit Audition/Proposal on this Project